
NDR Medical makes image-guided procedures safer and more accurate by automating lesion detection and needle targeting for percutaneous interventions. The company combines AI and robotics in systems such as ANT-C and ANT-X, integrating with CT-scan imaging and C-arm fluoroscopy to automate lesion detection, needle path planning, and precise needle placement. Its technology targets procedures in the lung, liver, kidney, spine and other organs and is aimed at interventional radiologists and surgeons. ANT-X has received FDA clearance and the company collaborates with clinical partners including Stanford Medicine and the Veterans Affairs Palo Alto Health Care System. NDR Medical operates in the medtech B2B space, offering device-plus-software solutions to hospitals and surgical centers.

NDR Medical makes image-guided procedures safer and more accurate by automating lesion detection and needle targeting for percutaneous interventions. The company combines AI and robotics in systems such as ANT-C and ANT-X, integrating with CT-scan imaging and C-arm fluoroscopy to automate lesion detection, needle path planning, and precise needle placement. Its technology targets procedures in the lung, liver, kidney, spine and other organs and is aimed at interventional radiologists and surgeons. ANT-X has received FDA clearance and the company collaborates with clinical partners including Stanford Medicine and the Veterans Affairs Palo Alto Health Care System. NDR Medical operates in the medtech B2B space, offering device-plus-software solutions to hospitals and surgical centers.